Global Non-invasive Neuromodulation Device Market Growth 2020-2025
According to this study, over the next five years the Non-invasive Neuromodulation Device market will register a XX%% CAGR in terms of revenue, the global market size will reach $ XX million by 2025, from $ XX million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Non-invasive Neuromodulation Device business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-invasive Neuromodulation Device market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Non-invasive Neuromodulation Device, covering the supply chain analysis, impact assessment to the Non-invasive Neuromodulation Device market size growth rate in several scenarios, and the measures to be undertaken by Non-invasive Neuromodulation Device companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Transcranial Direct Current Stimulation (tDCS)
Transcranial Alternating Current Stimulation (tACS)
Transcranial Pulsed Current Stimulation (tPCS)
Transcranial Random Noise Stimulation (tRNS)
Electroconvulsive therapy (ECT)
Others
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Clinic
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Neuroelectrics
Shenzhen Hanix United
Magstim
Soterix Medical
Newronika
NeuroCare Group
Philips Healthcare
Rogue Resolutions
Shenzhen Yingchi Technology
Medtronic
Shanghai Qiankang Medical Care Company
EB Neuro SpA
TCT Research
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Non-invasive Neuromodulation Device consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Non-invasive Neuromodulation Device market by identifying its various subsegments.
Focuses on the key global Non-invasive Neuromodulation Device manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Non-invasive Neuromodulation Device with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Non-invasive Neuromodulation Device submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Non-invasive Neuromodulation Device Consumption 2015-2025
2.1.2 Non-invasive Neuromodulation Device Consumption CAGR by Region
2.2 Non-invasive Neuromodulation Device Segment by Type
2.2.1 Transcranial Direct Current Stimulation (tDCS)
2.2.2 Transcranial Alternating Current Stimulation (tACS)
2.2.3 Transcranial Pulsed Current Stimulation (tPCS)
2.2.4 Transcranial Random Noise Stimulation (tRNS)
2.2.5 Electroconvulsive therapy (ECT)
2.2.6 Others
2.3 Non-invasive Neuromodulation Device Consumption by Type
2.3.1 Global Non-invasive Neuromodulation Device Consumption Market Share by Type (2015-2020)
2.3.2 Global Non-invasive Neuromodulation Device Revenue and Market Share by Type (2015-2020)
2.3.3 Global Non-invasive Neuromodulation Device Sale Price by Type (2015-2020)
2.4 Non-invasive Neuromodulation Device Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Non-invasive Neuromodulation Device Consumption by Application
2.5.1 Global Non-invasive Neuromodulation Device Consumption Market Share by Type (2015-2020)
2.5.2 Global Non-invasive Neuromodulation Device Value and Market Share by Type (2015-2020)
2.5.3 Global Non-invasive Neuromodulation Device Sale Price by Type (2015-2020)
3 Global Non-invasive Neuromodulation Device by Company
3.1 Global Non-invasive Neuromodulation Device Sales Market Share by Company
3.1.1 Global Non-invasive Neuromodulation Device Sales by Company (2018-2020)
3.1.2 Global Non-invasive Neuromodulation Device Sales Market Share by Company (2018-2020)
3.2 Global Non-invasive Neuromodulation Device Revenue Market Share by Company
3.2.1 Global Non-invasive Neuromodulation Device Revenue by Company (2018-2020)
3.2.2 Global Non-invasive Neuromodulation Device Revenue Market Share by Company (2018-2020)
3.3 Global Non-invasive Neuromodulation Device Sale Price by Company
3.4 Global Non-invasive Neuromodulation Device Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Non-invasive Neuromodulation Device Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Non-invasive Neuromodulation Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Non-invasive Neuromodulation Device by Regions
4.1 Non-invasive Neuromodulation Device by Regions
4.2 Americas Non-invasive Neuromodulation Device Consumption Growth
4.3 APAC Non-invasive Neuromodulation Device Consumption Growth
4.4 Europe Non-invasive Neuromodulation Device Consumption Growth
4.5 Middle East & Africa Non-invasive Neuromodulation Device Consumption Growth
5 Americas
5.1 Americas Non-invasive Neuromodulation Device Consumption by Countries
5.1.1 Americas Non-invasive Neuromodulation Device Consumption by Countries (2015-2020)
5.1.2 Americas Non-invasive Neuromodulation Device Value by Countries (2015-2020)
5.2 Americas Non-invasive Neuromodulation Device Consumption by Type
5.3 Americas Non-invasive Neuromodulation Device Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Non-invasive Neuromodulation Device Consumption by Regions
6.1.1 APAC Non-invasive Neuromodulation Device Consumption by Regions (2015-2020)
6.1.2 APAC Non-invasive Neuromodulation Device Value by Regions (2015-2020)
6.2 APAC Non-invasive Neuromodulation Device Consumption by Type
6.3 APAC Non-invasive Neuromodulation Device Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Non-invasive Neuromodulation Device by Countries
7.1.1 Europe Non-invasive Neuromodulation Device Consumption by Countries (2015-2020)
7.1.2 Europe Non-invasive Neuromodulation Device Value by Countries (2015-2020)
7.2 Europe Non-invasive Neuromodulation Device Consumption by Type
7.3 Europe Non-invasive Neuromodulation Device Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Non-invasive Neuromodulation Device by Countries
8.1.1 Middle East & Africa Non-invasive Neuromodulation Device Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Non-invasive Neuromodulation Device Value by Countries (2015-2020)
8.2 Middle East & Africa Non-invasive Neuromodulation Device Consumption by Type
8.3 Middle East & Africa Non-invasive Neuromodulation Device Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Non-invasive Neuromodulation Device Distributors
10.3 Non-invasive Neuromodulation Device Customer
11 Global Non-invasive Neuromodulation Device Market Forecast
11.1 Global Non-invasive Neuromodulation Device Consumption Forecast (2021-2025)
11.2 Global Non-invasive Neuromodulation Device Forecast by Regions
11.2.1 Global Non-invasive Neuromodulation Device Forecast by Regions (2021-2025)
11.2.2 Global Non-invasive Neuromodulation Device Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Non-invasive Neuromodulation Device Forecast by Type
11.8 Global Non-invasive Neuromodulation Device Forecast by Application
12 Key Players Analysis
12.1 Neuroelectrics
12.1.1 Company Information
12.1.2 Non-invasive Neuromodulation Device Product Offered
12.1.3 Neuroelectrics Non-invasive Neuromodulation Device Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Neuroelectrics Latest Developments
12.2 Shenzhen Hanix United
12.2.1 Company Information
12.2.2 Non-invasive Neuromodulation Device Product Offered
12.2.3 Shenzhen Hanix United Non-invasive Neuromodulation Device Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Shenzhen Hanix United Latest Developments
12.3 Magstim
12.3.1 Company Information
12.3.2 Non-invasive Neuromodulation Device Product Offered
12.3.3 Magstim Non-invasive Neuromodulation Device Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Magstim Latest Developments
12.4 Soterix Medical
12.4.1 Company Information
12.4.2 Non-invasive Neuromodulation Device Product Offered
12.4.3 Soterix Medical Non-invasive Neuromodulation Device Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Soterix Medical Latest Developments
12.5 Newronika
12.5.1 Company Information
12.5.2 Non-invasive Neuromodulation Device Product Offered
12.5.3 Newronika Non-invasive Neuromodulation Device Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Newronika Latest Developments
12.6 NeuroCare Group
12.6.1 Company Information
12.6.2 Non-invasive Neuromodulation Device Product Offered
12.6.3 NeuroCare Group Non-invasive Neuromodulation Device Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 NeuroCare Group Latest Developments
12.7 Philips Healthcare
12.7.1 Company Information
12.7.2 Non-invasive Neuromodulation Device Product Offered
12.7.3 Philips Healthcare Non-invasive Neuromodulation Device Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Philips Healthcare Latest Developments
12.8 Rogue Resolutions
12.8.1 Company Information
12.8.2 Non-invasive Neuromodulation Device Product Offered
12.8.3 Rogue Resolutions Non-invasive Neuromodulation Device Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Rogue Resolutions Latest Developments
12.9 Shenzhen Yingchi Technology
12.9.1 Company Information
12.9.2 Non-invasive Neuromodulation Device Product Offered
12.9.3 Shenzhen Yingchi Technology Non-invasive Neuromodulation Device Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Shenzhen Yingchi Technology Latest Developments
12.10 Medtronic
12.10.1 Company Information
12.10.2 Non-invasive Neuromodulation Device Product Offered
12.10.3 Medtronic Non-invasive Neuromodulation Device Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Medtronic Latest Developments
12.11 Shanghai Qiankang Medical Care Company
12.11.1 Company Information
12.11.2 Non-invasive Neuromodulation Device Product Offered
12.11.3 Shanghai Qiankang Medical Care Company Non-invasive Neuromodulation Device Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Shanghai Qiankang Medical Care Company Latest Developments
12.12 EB Neuro SpA
12.12.1 Company Information
12.12.2 Non-invasive Neuromodulation Device Product Offered
12.12.3 EB Neuro SpA Non-invasive Neuromodulation Device Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 EB Neuro SpA Latest Developments
12.13 TCT Research
12.13.1 Company Information
12.13.2 Non-invasive Neuromodulation Device Product Offered
12.13.3 TCT Research Non-invasive Neuromodulation Device Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 TCT Research Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Non-invasive Neuromodulation Device Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Transcranial Direct Current Stimulation (tDCS)
Table 5. Major Players of Transcranial Alternating Current Stimulation (tACS)
Table 6. Major Players of Transcranial Pulsed Current Stimulation (tPCS)
Table 7. Major Players of Transcranial Random Noise Stimulation (tRNS)
Table 8. Major Players of Electroconvulsive therapy (ECT)
Table 9. Major Players of Others
Table 10. Global Consumption Sales by Type (2015-2020)
Table 11. Global Non-invasive Neuromodulation Device Consumption Market Share by Type (2015-2020)
Table 12. Global Non-invasive Neuromodulation Device Revenue by Type (2015-2020) ($ million)
Table 13. Global Non-invasive Neuromodulation Device Value Market Share by Type (2015-2020) ($ Millions)
Table 14. Global Non-invasive Neuromodulation Device Sale Price by Type (2015-2020)
Table 15. Global Consumption Sales by Application (2015-2020)
Table 16. Global Non-invasive Neuromodulation Device Consumption Market Share by Application (2015-2020)
Table 17. Global Non-invasive Neuromodulation Device Value by Application (2015-2020)
Table 18. Global Non-invasive Neuromodulation Device Value Market Share by Application (2015-2020)
Table 19. Global Non-invasive Neuromodulation Device Sale Price by Application (2015-2020)
Table 20. Global Non-invasive Neuromodulation Device Sales by Company (2017-2019) (K Units)
Table 21. Global Non-invasive Neuromodulation Device Sales Market Share by Company (2017-2019)
Table 22. Global Non-invasive Neuromodulation Device Revenue by Company (2017-2019) ($ Millions)
Table 23. Global Non-invasive Neuromodulation Device Revenue Market Share by Company (2017-2019)
Table 24. Global Non-invasive Neuromodulation Device Sale Price by Company (2017-2019)
Table 25. Global Non-invasive Neuromodulation Device Manufacturing Base Distribution and Sales Area by Manufacturers
Table 26. Players Non-invasive Neuromodulation Device Products Offered
Table 27. Non-invasive Neuromodulation Device Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 28. Global Non-invasive Neuromodulation Device Consumption by Regions 2015-2020 (K Units)
Table 29. Global Non-invasive Neuromodulation Device Consumption Market Share by Regions 2015-2020
Table 30. Global Non-invasive Neuromodulation Device Value by Regions 2015-2020 ($ Millions)
Table 31. Global Non-invasive Neuromodulation Device Value Market Share by Regions 2015-2020
Table 32. Americas Non-invasive Neuromodulation Device Consumption by Countries (2015-2020) (K Units)
Table 33. Americas Non-invasive Neuromodulation Device Consumption Market Share by Countries (2015-2020)
Table 34. Americas Non-invasive Neuromodulation Device Value by Countries (2015-2020) ($ Millions)
Table 35. Americas Non-invasive Neuromodulation Device Value Market Share by Countries (2015-2020)
Table 36. Americas Non-invasive Neuromodulation Device Consumption by Type (2015-2020) (K Units)
Table 37. Americas Non-invasive Neuromodulation Device Consumption Market Share by Type (2015-2020)
Table 38. Americas Non-invasive Neuromodulation Device Consumption by Application (2015-2020) (K Units)
Table 39. Americas Non-invasive Neuromodulation Device Consumption Market Share by Application (2015-2020)
Table 40. APAC Non-invasive Neuromodulation Device Consumption by Countries (2015-2020) (K Units)
Table 41. APAC Non-invasive Neuromodulation Device Consumption Market Share by Countries (2015-2020)
Table 42. APAC Non-invasive Neuromodulation Device Value by Regions (2015-2020) ($ Millions)
Table 43. APAC Non-invasive Neuromodulation Device Value Market Share by Regions (2015-2020)
Table 44. APAC Non-invasive Neuromodulation Device Consumption by Type (2015-2020) (K Units)
Table 45. APAC Non-invasive Neuromodulation Device Consumption Market Share by Type (2015-2020)
Table 46. APAC Non-invasive Neuromodulation Device Consumption by Application (2015-2020) (K Units)
Table 47. APAC Non-invasive Neuromodulation Device Consumption Market Share by Application (2015-2020)
Table 48. Europe Non-invasive Neuromodulation Device Consumption by Countries (2015-2020) (K Units)
Table 49. Europe Non-invasive Neuromodulation Device Consumption Market Share by Countries (2015-2020)
Table 50. Europe Non-invasive Neuromodulation Device Value by Countries (2015-2020) ($ Millions)
Table 51. Europe Non-invasive Neuromodulation Device Value Market Share by Countries (2015-2020)
Table 52. Europe Non-invasive Neuromodulation Device Consumption by Type (2015-2020) (K Units)
Table 53. Europe Non-invasive Neuromodulation Device Consumption Market Share by Type (2015-2020)
Table 54. Europe Non-invasive Neuromodulation Device Consumption by Application (2015-2020) (K Units)
Table 55. Europe Non-invasive Neuromodulation Device Consumption Market Share by Application (2015-2020)
Table 56. Middle East & Africa Non-invasive Neuromodulation Device Consumption by Countries (2015-2020) (K Units)
Table 57. Middle East & Africa Non-invasive Neuromodulation Device Consumption Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Non-invasive Neuromodulation Device Value by Countries (2015-2020) ($ Millions)
Table 59. Middle East & Africa Non-invasive Neuromodulation Device Value Market Share by Countries (2015-2020)
Table 60. Middle East & Africa Non-invasive Neuromodulation Device Consumption by Type (2015-2020) (K Units)
Table 61. Middle East & Africa Non-invasive Neuromodulation Device Consumption Market Share by Type (2015-2020)
Table 62. Middle East & Africa Non-invasive Neuromodulation Device Consumption by Application (2015-2020) (K Units)
Table 63. Middle East & Africa Non-invasive Neuromodulation Device Consumption Market Share by Application (2015-2020)
Table 64. Non-invasive Neuromodulation Device Distributors List
Table 65. Non-invasive Neuromodulation Device Customer List
Table 66. Global Non-invasive Neuromodulation Device Consumption Forecast by Countries (2021-2025) (K Units)
Table 67. Global Non-invasive Neuromodulation Device Consumption Market Forecast by Regions
Table 68. Global Non-invasive Neuromodulation Device Value Forecast by Countries (2021-2025) ($ Millions)
Table 69. Global Non-invasive Neuromodulation Device Value Market Share Forecast by Regions
Table 70. Global Non-invasive Neuromodulation Device Consumption Forecast by Type (2021-2025) (K Units)
Table 71. Global Non-invasive Neuromodulation Device Consumption Market Share Forecast by Type (2021-2025)
Table 72. Global Non-invasive Neuromodulation Device Value Forecast by Type (2021-2025) ($ Millions)
Table 73. Global Non-invasive Neuromodulation Device Value Market Share Forecast by Type (2021-2025)
Table 74. Global Non-invasive Neuromodulation Device Consumption Forecast by Application (2021-2025) (K Units)
Table 75. Global Non-invasive Neuromodulation Device Consumption Market Share Forecast by Application (2021-2025)
Table 76. Global Non-invasive Neuromodulation Device Value Forecast by Application (2021-2025) ($ Millions)
Table 77. Global Non-invasive Neuromodulation Device Value Market Share Forecast by Application (2021-2025)
Table 78. Neuroelectrics Product Offered
Table 79. Neuroelectrics Non-invasive Neuromodulation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 80. Neuroelectrics Main Business
Table 81. Neuroelectrics Latest Developments
Table 82. Neuroelectrics Basic Information, Company Total Revenue (in $ million), Non-invasive Neuromodulation Device Manufacturing Base, Sales Area and Its Competitors
Table 83. Shenzhen Hanix United Product Offered
Table 84. Shenzhen Hanix United Non-invasive Neuromodulation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 85. Shenzhen Hanix United Main Business
Table 86. Shenzhen Hanix United Latest Developments
Table 87. Shenzhen Hanix United Basic Information, Company Total Revenue (in $ million), Non-invasive Neuromodulation Device Manufacturing Base, Sales Area and Its Competitors
Table 88. Magstim Product Offered
Table 89. Magstim Non-invasive Neuromodulation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 90. Magstim Main Business
Table 91. Magstim Latest Developments
Table 92. Magstim Basic Information, Company Total Revenue (in $ million), Non-invasive Neuromodulation Device Manufacturing Base, Sales Area and Its Competitors
Table 93. Soterix Medical Product Offered
Table 94. Soterix Medical Non-invasive Neuromodulation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 95. Soterix Medical Main Business
Table 96. Soterix Medical Latest Developments
Table 97. Soterix Medical Basic Information, Company Total Revenue (in $ million), Non-invasive Neuromodulation Device Manufacturing Base, Sales Area and Its Competitors
Table 98. Newronika Product Offered
Table 99. Newronika Non-invasive Neuromodulation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 100. Newronika Main Business
Table 101. Newronika Latest Developments
Table 102. Newronika Basic Information, Company Total Revenue (in $ million), Non-invasive Neuromodulation Device Manufacturing Base, Sales Area and Its Competitors
Table 103. NeuroCare Group Product Offered
Table 104. NeuroCare Group Non-invasive Neuromodulation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 105. NeuroCare Group Main Business
Table 106. NeuroCare Group Latest Developments
Table 107. NeuroCare Group Basic Information, Company Total Revenue (in $ million), Non-invasive Neuromodulation Device Manufacturing Base, Sales Area and Its Competitors
Table 108. Philips Healthcare Product Offered
Table 109. Philips Healthcare Basic Information, Company Total Revenue (in $ million), Non-invasive Neuromodulation Device Manufacturing Base, Sales Area and Its Competitors
Table 110. Philips Healthcare Main Business
Table 111. Philips Healthcare Latest Developments
Table 112. Philips Healthcare Non-invasive Neuromodulation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 113. Rogue Resolutions Product Offered
Table 114. Rogue Resolutions Non-invasive Neuromodulation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 115. Rogue Resolutions Main Business
Table 116. Rogue Resolutions Latest Developments
Table 117. Rogue Resolutions Basic Information, Company Total Revenue (in $ million), Non-invasive Neuromodulation Device Manufacturing Base, Sales Area and Its Competitors
Table 118. Shenzhen Yingchi Technology Product Offered
Table 119. Shenzhen Yingchi Technology Non-invasive Neuromodulation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 120. Shenzhen Yingchi Technology Main Business
Table 121. Shenzhen Yingchi Technology Latest Developments
Table 122. Shenzhen Yingchi Technology Basic Information, Company Total Revenue (in $ million), Non-invasive Neuromodulation Device Manufacturing Base, Sales Area and Its Competitors
Table 123. Medtronic Product Offered
Table 124. Medtronic Non-invasive Neuromodulation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 125. Medtronic Main Business
Table 126. Medtronic Latest Developments
Table 127. Medtronic Basic Information, Company Total Revenue (in $ million), Non-invasive Neuromodulation Device Manufacturing Base, Sales Area and Its Competitors
Table 128. Shanghai Qiankang Medical Care Company Product Offered
Table 129. Shanghai Qiankang Medical Care Company Non-invasive Neuromodulation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 130. Shanghai Qiankang Medical Care Company Main Business
Table 131. Shanghai Qiankang Medical Care Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 132. Shanghai Qiankang Medical Care Company Latest Developments
Table 133. EB Neuro SpA Product Offered
Table 134. EB Neuro SpA Non-invasive Neuromodulation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 135. EB Neuro SpA Main Business
Table 136. EB Neuro SpA Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 137. EB Neuro SpA Latest Developments
Table 138. TCT Research Product Offered
Table 139. TCT Research Non-invasive Neuromodulation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 140. TCT Research Main Business
Table 141. TCT Research Latest Developments
Table 142. TCT Research Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Non-invasive Neuromodulation Device
Figure 2. Non-invasive Neuromodulation Device Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Non-invasive Neuromodulation Device Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Non-invasive Neuromodulation Device Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Transcranial Direct Current Stimulation (tDCS)
Figure 7. Product Picture of Transcranial Alternating Current Stimulation (tACS)
Figure 8. Product Picture of Transcranial Pulsed Current Stimulation (tPCS)
Figure 9. Product Picture of Transcranial Random Noise Stimulation (tRNS)
Figure 10. Product Picture of Electroconvulsive therapy (ECT)
Figure 11. Product Picture of Others
Figure 12. Global Non-invasive Neuromodulation Device Consumption Market Share by Type (2015-2020)
Figure 13. Global Non-invasive Neuromodulation Device Value Market Share by Type (2015-2020)
Figure 14. Non-invasive Neuromodulation Device Consumed in Hospital
Figure 15. Global Non-invasive Neuromodulation Device Market: Hospital (2015-2020) (K Units)
Figure 16. Global Non-invasive Neuromodulation Device Market: Hospital (2015-2020) ($ Millions)
Figure 17. Non-invasive Neuromodulation Device Consumed in Clinic
Figure 18. Global Non-invasive Neuromodulation Device Market: Clinic (2015-2020) (K Units)
Figure 19. Global Non-invasive Neuromodulation Device Market: Clinic (2015-2020) ($ Millions)
Figure 20. Non-invasive Neuromodulation Device Consumed in Others
Figure 21. Global Non-invasive Neuromodulation Device Market: Others (2015-2020) (K Units)
Figure 22. Global Non-invasive Neuromodulation Device Market: Others (2015-2020) ($ Millions)
Figure 23. Global Non-invasive Neuromodulation Device Consumption Market Share by Application (2015-2020)
Figure 24. Global Non-invasive Neuromodulation Device Value Market Share by Application (2015-2020)
Figure 25. Global Non-invasive Neuromodulation Device Sales Market Share by Company in 2017
Figure 26. Global Non-invasive Neuromodulation Device Sales Market Share by Company in 2019
Figure 27. Global Non-invasive Neuromodulation Device Revenue Market Share by Company in 2017
Figure 28. Global Non-invasive Neuromodulation Device Revenue Market Share by Company in 2019
Figure 29. Global Non-invasive Neuromodulation Device Sale Price by Company in 2019
Figure 30. Global Non-invasive Neuromodulation Device Consumption Market Share by Regions 2015-2020
Figure 31. Global Non-invasive Neuromodulation Device Value Market Share by Regions 2015-2020
Figure 32. Americas Non-invasive Neuromodulation Device Consumption 2015-2020 (K Units)
Figure 33. Americas Non-invasive Neuromodulation Device Value 2015-2020 ($ Millions)
Figure 34. APAC Non-invasive Neuromodulation Device Consumption 2015-2020 (K Units)
Figure 35. APAC Non-invasive Neuromodulation Device Value 2015-2020 ($ Millions)
Figure 36. Europe Non-invasive Neuromodulation Device Consumption 2015-2020 (K Units)
Figure 37. Europe Non-invasive Neuromodulation Device Value 2015-2020 ($ Millions)
Figure 38. Middle East & Africa Non-invasive Neuromodulation Device Consumption 2015-2020 (K Units)
Figure 39. Middle East & Africa Non-invasive Neuromodulation Device Value 2015-2020 ($ Millions)
Figure 40. Americas Non-invasive Neuromodulation Device Consumption Market Share by Countries in 2019
Figure 41. Americas Non-invasive Neuromodulation Device Value Market Share by Countries in 2019
Figure 42. Americas Non-invasive Neuromodulation Device Consumption Market Share by Type in 2019
Figure 43. Americas Non-invasive Neuromodulation Device Consumption Market Share by Application in 2019
Figure 44. United States Non-invasive Neuromodulation Device Consumption Growth 2015-2020 (K Units)
Figure 45. United States Non-invasive Neuromodulation Device Value Growth 2015-2020 ($ Millions)
Figure 46. Canada Non-invasive Neuromodulation Device Consumption Growth 2015-2020 (K Units)
Figure 47. Canada Non-invasive Neuromodulation Device Value Growth 2015-2020 ($ Millions)
Figure 48. Mexico Non-invasive Neuromodulation Device Consumption Growth 2015-2020 (K Units)
Figure 49. Mexico Non-invasive Neuromodulation Device Value Growth 2015-2020 ($ Millions)
Figure 50. APAC Non-invasive Neuromodulation Device Consumption Market Share by Countries in 2019
Figure 51. APAC Non-invasive Neuromodulation Device Value Market Share by Regions in 2019
Figure 52. APAC Non-invasive Neuromodulation Device Consumption Market Share by Type in 2019
Figure 53. APAC Non-invasive Neuromodulation Device Consumption Market Share by Application in 2019
Figure 54. China Non-invasive Neuromodulation Device Consumption Growth 2015-2020 (K Units)
Figure 55. China Non-invasive Neuromodulation Device Value Growth 2015-2020 ($ Millions)
Figure 56. Japan Non-invasive Neuromodulation Device Consumption Growth 2015-2020 (K Units)
Figure 57. Japan Non-invasive Neuromodulation Device Value Growth 2015-2020 ($ Millions)
Figure 58. Korea Non-invasive Neuromodulation Device Consumption Growth 2015-2020 (K Units)
Figure 59. Korea Non-invasive Neuromodulation Device Value Growth 2015-2020 ($ Millions)
Figure 60. Southeast Asia Non-invasive Neuromodulation Device Consumption Growth 2015-2020 (K Units)
Figure 61. Southeast Asia Non-invasive Neuromodulation Device Value Growth 2015-2020 ($ Millions)
Figure 62. India Non-invasive Neuromodulation Device Consumption Growth 2015-2020 (K Units)
Figure 63. India Non-invasive Neuromodulation Device Value Growth 2015-2020 ($ Millions)
Figure 64. Australia Non-invasive Neuromodulation Device Consumption Growth 2015-2020 (K Units)
Figure 65. Australia Non-invasive Neuromodulation Device Value Growth 2015-2020 ($ Millions)
Figure 66. Europe Non-invasive Neuromodulation Device Consumption Market Share by Countries in 2019
Figure 67. Europe Non-invasive Neuromodulation Device Value Market Share by Countries in 2019
Figure 68. Europe Non-invasive Neuromodulation Device Consumption Market Share by Type in 2019
Figure 69. Europe Non-invasive Neuromodulation Device Consumption Market Share by Application in 2019
Figure 70. Germany Non-invasive Neuromodulation Device Consumption Growth 2015-2020 (K Units)
Figure 71. Germany Non-invasive Neuromodulation Device Value Growth 2015-2020 ($ Millions)
Figure 72. France Non-invasive Neuromodulation Device Consumption Growth 2015-2020 (K Units)
Figure 73. France Non-invasive Neuromodulation Device Value Growth 2015-2020 ($ Millions)
Figure 74. UK Non-invasive Neuromodulation Device Consumption Growth 2015-2020 (K Units)
Figure 75. UK Non-invasive Neuromodulation Device Value Growth 2015-2020 ($ Millions)
Figure 76. Italy Non-invasive Neuromodulation Device Consumption Growth 2015-2020 (K Units)
Figure 77. Italy Non-invasive Neuromodulation Device Value Growth 2015-2020 ($ Millions)
Figure 78. Russia Non-invasive Neuromodulation Device Consumption Growth 2015-2020 (K Units)
Figure 79. Russia Non-invasive Neuromodulation Device Value Growth 2015-2020 ($ Millions)
Figure 80. Middle East & Africa Non-invasive Neuromodulation Device Consumption Market Share by Countries in 2019
Figure 81. Middle East & Africa Non-invasive Neuromodulation Device Value Market Share by Countries in 2019
Figure 82. Middle East & Africa Non-invasive Neuromodulation Device Consumption Market Share by Type in 2019
Figure 83. Middle East & Africa Non-invasive Neuromodulation Device Consumption Market Share by Application in 2019
Figure 84. Egypt Non-invasive Neuromodulation Device Consumption Growth 2015-2020 (K Units)
Figure 85. Egypt Non-invasive Neuromodulation Device Value Growth 2015-2020 ($ Millions)
Figure 86. South Africa Non-invasive Neuromodulation Device Consumption Growth 2015-2020 (K Units)
Figure 87. South Africa Non-invasive Neuromodulation Device Value Growth 2015-2020 ($ Millions)
Figure 88. Israel Non-invasive Neuromodulation Device Consumption Growth 2015-2020 (K Units)
Figure 89. Israel Non-invasive Neuromodulation Device Value Growth 2015-2020 ($ Millions)
Figure 90. Turkey Non-invasive Neuromodulation Device Consumption Growth 2015-2020 (K Units)
Figure 91. Turkey Non-invasive Neuromodulation Device Value Growth 2015-2020 ($ Millions)
Figure 92. GCC Countries Non-invasive Neuromodulation Device Consumption Growth 2015-2020 (K Units)
Figure 93. GCC Countries Non-invasive Neuromodulation Device Value Growth 2015-2020 ($ Millions)
Figure 94. Global Non-invasive Neuromodulation Device Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 95. Global Non-invasive Neuromodulation Device Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 96. Americas Non-invasive Neuromodulation Device Consumption 2021-2025 (K Units)
Figure 97. Americas Non-invasive Neuromodulation Device Value 2021-2025 ($ Millions)
Figure 98. APAC Non-invasive Neuromodulation Device Consumption 2021-2025 (K Units)
Figure 99. APAC Non-invasive Neuromodulation Device Value 2021-2025 ($ Millions)
Figure 100. Europe Non-invasive Neuromodulation Device Consumption 2021-2025 (K Units)
Figure 101. Europe Non-invasive Neuromodulation Device Value 2021-2025 ($ Millions)
Figure 102. Middle East & Africa Non-invasive Neuromodulation Device Consumption 2021-2025 (K Units)
Figure 103. Middle East & Africa Non-invasive Neuromodulation Device Value 2021-2025 ($ Millions)
Figure 104. United States Non-invasive Neuromodulation Device Consumption 2021-2025 (K Units)
Figure 105. United States Non-invasive Neuromodulation Device Value 2021-2025 ($ Millions)
Figure 106. Canada Non-invasive Neuromodulation Device Consumption 2021-2025 (K Units)
Figure 107. Canada Non-invasive Neuromodulation Device Value 2021-2025 ($ Millions)
Figure 108. Mexico Non-invasive Neuromodulation Device Consumption 2021-2025 (K Units)
Figure 109. Mexico Non-invasive Neuromodulation Device Value 2021-2025 ($ Millions)
Figure 110. Brazil Non-invasive Neuromodulation Device Consumption 2021-2025 (K Units)
Figure 111. Brazil Non-invasive Neuromodulation Device Value 2021-2025 ($ Millions)
Figure 112. China Non-invasive Neuromodulation Device Consumption 2021-2025 (K Units)
Figure 113. China Non-invasive Neuromodulation Device Value 2021-2025 ($ Millions)
Figure 114. Japan Non-invasive Neuromodulation Device Consumption 2021-2025 (K Units)
Figure 115. Japan Non-invasive Neuromodulation Device Value 2021-2025 ($ Millions)
Figure 116. Korea Non-invasive Neuromodulation Device Consumption 2021-2025 (K Units)
Figure 117. Korea Non-invasive Neuromodulation Device Value 2021-2025 ($ Millions)
Figure 118. Southeast Asia Non-invasive Neuromodulation Device Consumption 2021-2025 (K Units)
Figure 119. Southeast Asia Non-invasive Neuromodulation Device Value 2021-2025 ($ Millions)
Figure 120. India Non-invasive Neuromodulation Device Consumption 2021-2025 (K Units)
Figure 121. India Non-invasive Neuromodulation Device Value 2021-2025 ($ Millions)
Figure 122. Australia Non-invasive Neuromodulation Device Consumption 2021-2025 (K Units)
Figure 123. Australia Non-invasive Neuromodulation Device Value 2021-2025 ($ Millions)
Figure 124. Germany Non-invasive Neuromodulation Device Consumption 2021-2025 (K Units)
Figure 125. Germany Non-invasive Neuromodulation Device Value 2021-2025 ($ Millions)
Figure 126. France Non-invasive Neuromodulation Device Consumption 2021-2025 (K Units)
Figure 127. France Non-invasive Neuromodulation Device Value 2021-2025 ($ Millions)
Figure 128. UK Non-invasive Neuromodulation Device Consumption 2021-2025 (K Units)
Figure 129. UK Non-invasive Neuromodulation Device Value 2021-2025 ($ Millions)
Figure 130. Italy Non-invasive Neuromodulation Device Consumption 2021-2025 (K Units)
Figure 131. Italy Non-invasive Neuromodulation Device Value 2021-2025 ($ Millions)
Figure 132. Russia Non-invasive Neuromodulation Device Consumption 2021-2025 (K Units)
Figure 133. Russia Non-invasive Neuromodulation Device Value 2021-2025 ($ Millions)
Figure 134. Spain Non-invasive Neuromodulation Device Consumption 2021-2025 (K Units)
Figure 135. Spain Non-invasive Neuromodulation Device Value 2021-2025 ($ Millions)
Figure 136. Egypt Non-invasive Neuromodulation Device Consumption 2021-2025 (K Units)
Figure 137. Egypt Non-invasive Neuromodulation Device Value 2021-2025 ($ Millions)
Figure 138. South Africa Non-invasive Neuromodulation Device Consumption 2021-2025 (K Units)
Figure 139. South Africa Non-invasive Neuromodulation Device Value 2021-2025 ($ Millions)
Figure 140. Israel Non-invasive Neuromodulation Device Consumption 2021-2025 (K Units)
Figure 141. Israel Non-invasive Neuromodulation Device Value 2021-2025 ($ Millions)
Figure 142. Turkey Non-invasive Neuromodulation Device Consumption 2021-2025 (K Units)
Figure 143. Turkey Non-invasive Neuromodulation Device Value 2021-2025 ($ Millions)
Figure 144. GCC Countries Non-invasive Neuromodulation Device Consumption 2021-2025 (K Units)
Figure 145. GCC Countries Non-invasive Neuromodulation Device Value 2021-2025 ($ Millions)
Figure 146. Neuroelectrics Non-invasive Neuromodulation Device Market Share (2018-2020)
Figure 147. Shenzhen Hanix United Non-invasive Neuromodulation Device Market Share (2018-2020)
Figure 148. Magstim Non-invasive Neuromodulation Device Market Share (2018-2020)
Figure 149. Soterix Medical Non-invasive Neuromodulation Device Market Share (2018-2020)
Figure 150. Newronika Non-invasive Neuromodulation Device Market Share (2018-2020)
Figure 151. NeuroCare Group Non-invasive Neuromodulation Device Market Share (2018-2020)
Figure 152. Philips Healthcare Non-invasive Neuromodulation Device Market Share (2018-2020)
Figure 153. Rogue Resolutions Non-invasive Neuromodulation Device Market Share (2018-2020)
Figure 154. Shenzhen Yingchi Technology Non-invasive Neuromodulation Device Market Share (2018-2020)
Figure 155. Medtronic Non-invasive Neuromodulation Device Market Share (2018-2020)
Figure 156. Shanghai Qiankang Medical Care Company Non-invasive Neuromodulation Device Market Share (2018-2020)
Figure 157. EB Neuro SpA Non-invasive Neuromodulation Device Market Share (2018-2020)
Figure 158. TCT Research Non-invasive Neuromodulation Device Market Share (2018-2020)
